>
Switch to:

Antares Pharma Accounts Payable & Accrued Expense

: $45.5 Mil (As of Jun. 2021)
View and export this data going back to 1996. Start your Free Trial

Antares Pharma's quarterly accounts payable & accrued expense increased from Dec. 2020 ($37.3 Mil) to Mar. 2021 ($43.1 Mil) and increased from Mar. 2021 ($43.1 Mil) to Jun. 2021 ($45.5 Mil).

Antares Pharma's annual accounts payable & accrued expense increased from Dec. 2018 ($11.1 Mil) to Dec. 2019 ($24.9 Mil) and increased from Dec. 2019 ($24.9 Mil) to Dec. 2020 ($37.3 Mil).


Antares Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Antares Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antares Pharma Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Accounts Payable & Accrued Expense
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.89 5.96 11.14 24.95 37.27

Antares Pharma Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Accounts Payable & Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.40 40.86 37.27 43.14 45.45

Antares Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Antares Pharma Business Description

Antares Pharma logo
Industry
Traded in Other Exchanges
Address
100 Princeton South, Suite 300, Ewing, NJ, USA, 08628
Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.
Executives
Greenleaf Peter director ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Smith Karen L. director C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Powell Fred M officer: Executive Vice President & CFO C/O BEJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462
Garrity Thomas J director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: GARRITY THOMAS J a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Roche Robert P Jr director 41 MOORES ROAD FRAZER PA 19355
Apple Robert F director, officer: President & CEO C/O INKLINE PHARMACEUTICAL CO INC SENTRY PARK EAST 1720 WALTON ROAD BLUE BELL PA 19422
Jacob Leonard S director C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Graham Peter J officer: EVP General Counsel, Secretary 315 E. 72ND ST. APT 5E NEW YORK NY 10021
Gueth Anton director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: GUETH ANTON a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Samson Marvin director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SAMSON MARVIN a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Tursi James Patrick officer: EVP, Chief Medical Officer 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540
Gonella Jacques director C/O ANTARES PHARMA INC 707 EAGLEVIEW BLVD SUITE 414 EXTON PA 19341
Muckenhirn Keith E officer: VP/Controller & Interim CFO C/O ANTARES PHARMA, INC. 3905 ANNAPOLIS LANE N, SUITE 105 PLYMOUTH MN 55447
Fickenscher James E officer: Senior Vice President & CFO C/O AUXILIUM PHARMACEUTICALS, INC. 640 LEE ROAD CHESTERBROOK PA 19087
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE 37TH FLOOR NEW YORK NY 10017

Antares Pharma Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)